(Q34204929)

31 July 2017

1 reference

title

Biological and clinical implications of the MTHFR C677T polymorphism (English)

1 reference

31 July 2017

4

Refsum H

1 reference

31 July 2017

1

Ueland PM

1 reference

31 July 2017

5

Vollset SE

1 reference

31 July 2017

Hustad S

2

1 reference

31 July 2017

Schneede J

series ordinal

3

1 reference

31 July 2017

publication date

1 April 2001

1 reference

Trends in Pharmacological Sciences

31 July 2017

published in

1 reference

31 July 2017

volume

22

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

195-201

1 reference

Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Neural tube and craniofacial defects with special emphasis on folate pathway genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The controversy over homocysteine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Folate and carcinogenesis: evidence, mechanisms, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Homocysteine and cardiovascular disease: cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

1 reference

7 January 2021

Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Allelic association of the MTHFR gene with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Trimethoprim and fasting plasma homocysteine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

A common mutation in the methylenetetrahydrofolate reductase gene is a determinant of hyperhomocysteinemia in epileptic patients receiving anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

A common methylenetetrahydrofolate reductase gene mutation and longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901675-8

7 January 2021

10.1016/S0165-6147(00)01675-8

Identifiers

DOI

1 reference

31 July 2017

1 reference